• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE EXCLUDER AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE EXCLUDER AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number PLC181000
Device Problem Unintended Movement (3026)
Patient Problem Aneurysm (1708)
Event Date 02/16/2021
Event Type  Injury  
Manufacturer Narrative
Additional devices implanted and/or related to this event: plc181000/(b)(4), udi (b)(4).Patient medications: lipitor, prilosec.The gore® excluder® aaa endoprosthesis instructions for use (ifu) states that adverse events that may occur and/or require intervention include, but are not limited to endoleak and component migration.
 
Event Description
On (b)(6) 2015, the patient was implanted with gore® excluder® aaa endoprostheses to treat an abdominal aortic aneurysm.It was reported that the patient had a distal type i endoleak (date and modality of images is unknown) and one of the implanted contralateral leg endoprosthesis had migrated proximally into the aneurysm sac.There is no aneurysm sac enlargement.A contralateral leg endoprosthesis was implanted in each iliac artery during the original procedure.It is unknown which of implanted contralateral leg endoprosthesis device had migrated therefore both will be reported on.On (b)(6) 2021, the physician reintervened and extended the left limb device which had pulled up into the aneurysm sac.Landing the proximal end at the flow divider and the distal end in the left external iliac.The aneurysm was resolved, and the patient tolerated the procedure.
 
Manufacturer Narrative
Revised h6: investigation findings to code 213 ¿ no device problem found.A review of the manufacturing records indicated the lot met pre-release specifications.Revised h6: investigation conclusion to code 22 ¿ known inherent risk of device.The gore® excluder® aaa endoprosthesis instructions for use (ifu) states that adverse events that may occur and/or require intervention include, but are not limited to endoleak and component migration.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE EXCLUDER AAA ENDOPROSTHESIS
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
MDR Report Key11360572
MDR Text Key232909350
Report Number3013164176-2021-01123
Device Sequence Number1
Product Code MIH
UDI-Device Identifier00733132618743
UDI-Public00733132618743
Combination Product (y/n)N
PMA/PMN Number
P020004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 08/10/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/22/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/26/2020
Device Model NumberPLC181000
Device Catalogue NumberPLC181000
Was Device Available for Evaluation? No
Date Manufacturer Received02/16/2021
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age65 YR
Patient Weight82
-
-